Please use this identifier to cite or link to this item:
https://doi.org/10.3390/ijms19051310
DC Field | Value | |
---|---|---|
dc.title | Noncoding RNA: RNA regulatory networks in cancer | |
dc.contributor.author | Chan, J.J | |
dc.contributor.author | Tay, Y | |
dc.date.accessioned | 2020-09-14T08:29:27Z | |
dc.date.available | 2020-09-14T08:29:27Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Chan, J.J, Tay, Y (2018). Noncoding RNA: RNA regulatory networks in cancer. International Journal of Molecular Sciences 19 (5) : 1310. ScholarBank@NUS Repository. https://doi.org/10.3390/ijms19051310 | |
dc.identifier.issn | 1661-6596 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/176205 | |
dc.description.abstract | Noncoding RNAs (ncRNAs) constitute the majority of the human transcribed genome. This largest class of RNA transcripts plays diverse roles in a multitude of cellular processes, and has been implicated inmany pathological conditions, especially cancer. The different subclasses of ncRNAs include microRNAs, a class of short ncRNAs; and a variety of long ncRNAs (lncRNAs), such as lincRNAs, antisense RNAs, pseudogenes, and circular RNAs. Many studies have demonstrated the involvement of these ncRNAs in competitive regulatory interactions, known as competing endogenous RNA (ceRNA) networks, whereby lncRNAs can act as microRNA decoys to modulate gene expression. These interactions are often interconnected, thus aberrant expression of any network component could derail the complex regulatory circuitry, culminating in cancer development and progression. Recent integrative analyses have provided evidence that new computational platforms and experimental approaches can be harnessed together to distinguish key ceRNA interactions in specific cancers, which could facilitate the identification of robust biomarkers and therapeutic targets, and hence, more effective cancer therapies and better patient outcome and survival. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.source | Unpaywall 20200831 | |
dc.subject | complementary RNA | |
dc.subject | cyclin E | |
dc.subject | cytohesin 1 | |
dc.subject | high mobility group A2 protein | |
dc.subject | long untranslated RNA | |
dc.subject | messenger RNA | |
dc.subject | microRNA | |
dc.subject | phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase | |
dc.subject | phosphatidylinositol 4,5 bisphosphate 3 kinase | |
dc.subject | pyruvate dehydrogenase kinase | |
dc.subject | RNA H19 | |
dc.subject | Smad7 protein | |
dc.subject | somatomedin B | |
dc.subject | STAT3 protein | |
dc.subject | transcription factor ZEB1 | |
dc.subject | transcriptome | |
dc.subject | tyrosinase related protein 1 | |
dc.subject | untranslated RNA | |
dc.subject | zinc finger E box binding homeobox 2 | |
dc.subject | long untranslated RNA | |
dc.subject | microRNA | |
dc.subject | RNA | |
dc.subject | RNA, circular | |
dc.subject | tumor marker | |
dc.subject | bioinformatics | |
dc.subject | breast cancer | |
dc.subject | cancer growth | |
dc.subject | colorectal carcinoma | |
dc.subject | DNA damage | |
dc.subject | epithelial mesenchymal transition | |
dc.subject | gallbladder cancer | |
dc.subject | gene control | |
dc.subject | gene expression | |
dc.subject | glioma | |
dc.subject | human | |
dc.subject | KRASP1 gene | |
dc.subject | liver cell carcinoma | |
dc.subject | malignant neoplasm | |
dc.subject | melanoma | |
dc.subject | mouth squamous cell carcinoma | |
dc.subject | NEAT1 gene | |
dc.subject | non small cell lung cancer | |
dc.subject | nonhuman | |
dc.subject | oncogene | |
dc.subject | pancreas cancer | |
dc.subject | phenotype | |
dc.subject | protein expression | |
dc.subject | pseudogene | |
dc.subject | regulatory RNA sequence | |
dc.subject | Review | |
dc.subject | signal transduction | |
dc.subject | stomach cancer | |
dc.subject | treatment outcome | |
dc.subject | tumor suppressor gene | |
dc.subject | TYRP1 gene | |
dc.subject | upregulation | |
dc.subject | carcinogenesis | |
dc.subject | gene expression profiling | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | neoplasm | |
dc.subject | RNA transport | |
dc.subject | Biomarkers, Tumor | |
dc.subject | Carcinogenesis | |
dc.subject | Gene Expression | |
dc.subject | Gene Expression Profiling | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | Humans | |
dc.subject | MicroRNAs | |
dc.subject | Neoplasms | |
dc.subject | Pseudogenes | |
dc.subject | RNA | |
dc.subject | RNA Transport | |
dc.subject | RNA, Long Noncoding | |
dc.type | Review | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | BIOCHEMISTRY | |
dc.description.doi | 10.3390/ijms19051310 | |
dc.description.sourcetitle | International Journal of Molecular Sciences | |
dc.description.volume | 19 | |
dc.description.issue | 5 | |
dc.description.page | 1310 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3390_ijms19051310.pdf | 1.84 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.